Add-on therapy

DRUG3 trials

Sponsors

Versailles Hospital, Galenika AD Beograd, Intarcia Therapeutics, Inc

Conditions

Leukemia, Myeloid, Chronic-PhaseResistant Hypertensionadd on therepy Type 2 Diabetes

Phase 2

Pioglityazone and Imatinib for CML Patients

CompletedNCT02888964

Versailles HospitalLeukemia, Myeloid, Chronic-Phase

Start: 2009-12-01End: 2016-02-01Updated: 2026-07-06

Phase 3

A Phase 3b, Randomized, Active Comparator, Open-label, Multicenter Study to Compare the Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and to Glimepiride as Add-on Therapy to Metformin in Patients with Type 2 Diabetes

Active, not recruitingNL-OMON45372

Intarcia Therapeutics, Incadd on therepy Type 2 Diabetes

Start: 2017-08-31Target: 21Updated: 2024-02-28

Unknown Phase

Treatment of Resistant Hypertension: Cohort Study

CompletedNCT05087940

Galenika AD BeogradResistant Hypertension

Start: 2021-06-01End: 2022-12-31Updated: 2023-02-22